Takeda says Meijer can't get quick appeal in US antitrust case over Amitiza
MLex Summary: Takeda Pharmaceuticals opposed Meijer’s request for leave to immediately appeal an order in a US antitrust case over Amitiza, saying certification of the arbitration order for interlocutory appeal would...To view the full article, register now.
Already a subscriber? Click here to view full article